Showing results (591-600 of 757) with videos related to

Sort By:
Pageof 76
Journal of Nephrology|September 28, 2024
First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical settingSusanne B Nicholas, Ricardo Correa-Rotter, Nihar R Desai, et al.
The New England Journal of Medicine|June 29, 2010
Everolimus in patients with autosomal dominant polycystic kidney diseaseGerd Walz, Klemens Budde, Marwan Mannaa, et al.
Circulation|November 6, 2022
A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 StudyHolger Reinecke, Christiane Engelbertz, Rupert Bauersachs, et al.
Kidney International|June 19, 2025
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAlberto Ortiz, José Manuel Arreola Guerra, Juliana C N Chan, et al.
Clinical Trials (London, England)|April 12, 2011
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney diseaseYili Pritchett, Yannis Jemiai, Yuchiao Chang, et al.
Orphanet Journal of Rare Diseases|July 1, 2016
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry diseaseMalte Lenders, Julia B Hennermann, Christine Kurschat, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2023
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup AnalysisPantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, et al.
Clinical Kidney Journal|November 6, 2025
Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL studyTilla C Folttmann, Antje M Haas, Nicholas C Chesnaye, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2022
Symptom Burden before and after Dialysis Initiation in Older PatientsEsther N M de Rooij, Yvette Meuleman, Johan W de Fijter, et al.
Molecular Genetics and Metabolism Reports|February 19, 2019
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of expertsDominique P Germain, Perry M Elliott, Bruno Falissard, et al.
Pageof 76